483
Biomat Holdings Mount Vernon NewarkFDA 483 - Biomat Holdings Mount Vernon Newark - July 15, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Biomat Holdings Mount Vernon Newark in Newark, OH, identified a significant concern regarding phlebotomy site preparation. Inspectors observed phlebotomists palpating venipuncture sites after needle insertion, which compromises the sterile field. This practice raises concerns about the sterility of collected source plasma units and adherence to proper aseptic technique.
- Person
Open in Dashboard
ID · c398a263-3549-4d2b-830e-a868c8055866